---
document_datetime: 2024-08-30 13:29:42
document_pages: 25
document_pathfilename: www.ema.europa.eu/en/documents/procedural-steps-after/ratiograstim-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf
document_name: ratiograstim-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf
version: success
processing_time: 14.633342
conversion_datetime: 2025-12-20 01:41:02.152625
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
## Ratiograstim

Procedural steps taken and scientific information after the authorisation

| Application number   | Scope                                                                                                                                                                                                                                                | Opinion/ Notification 1 issued on   | Commission Decision Issued 2 / amended on   | Product Information affected 3   | Summary   |
|----------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-------------------------------------|---------------------------------------------|----------------------------------|-----------|
| IB/0091/G            | This was an application for a group of variations. C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO | 21/08/2024                          |                                             | SmPC, Annex II and PL            |           |

1 Notifications are issued for type I variations and Article 61(3) notifications (unless part of a group including a type II variation or extension application or a worksharing application). Opinions are issued for all other procedures.

2 A Commission decision (CD) is issued for procedures that affect the terms of the marketing authorisation (e.g. summary of product characteristics, annex II, labelling, package leaflet). The CD is issued within two months of the opinion for variations falling under the scope of Article 23.1a(a) of Regulation (EU) No. 712/2012, or within one year for other procedures.

3 SmPC (Summary of Product Characteristics), Annex II, Labelling, PL (Package Leaflet).

<!-- image -->

<!-- image -->

<div style=\"page-break-after: always\"></div>

|           | new additional data is required to be submitted by the MAH A.7 - Administrative change - Deletion of manufacturing sites                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |            |     |
|-----------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|
| IB/0090   | B.I.b.1.z - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Other variation                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           | 11/06/2024 | n/a |
| IB/0089   | B.II.b.2.a - Change to importer, batch release arrangements and quality control testing of the FP - Replacement/addition of a site where batch control/testing takes place                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    | 08/05/2024 | n/a |
| IA/0088/G | This was an application for a group of variations. B.III.2.b - Change to comply with Ph. Eur. or with a national pharmacopoeia of a Member State - Change to comply with an update of the relevant monograph of the Ph. Eur. or national pharmacopoeia of a Member State B.I.b.1.d - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Deletion of a non- significant specification parameter (e.g. deletion of an obsolete parameter) A.5.b - Administrative change - Change in the name and/or address of a manufacturer/importer of the finished product, including quality control sites (excluding manufacturer for batch release) | 08/04/2024 | n/a |

<div style=\"page-break-after: always\"></div>

| IB/0087   | B.II.b.3.a - Change in the manufacturing process of the finished or intermediate product - Minor change in the manufacturing process                                                                                                                                                                                                                                                                                                                                       | 16/11/2023   | n/a   |           |
|-----------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|-------|-----------|
| IA/0086/G | This was an application for a group of variations. B.I.b.2.a - Change in test procedure for AS or starting material/reagent/intermediate - Minor changes to an approved test procedure B.I.b.2.a - Change in test procedure for AS or starting material/reagent/intermediate - Minor changes to an approved test procedure B.II.d.2.a - Change in test procedure for the finished product - Minor changes to an approved test                                              | 14/09/2023   | n/a   | procedure |
| IB/0085   | B.II.b.5.z - Change to in-process tests or limits applied during the manufacture of the finished product - Other variation                                                                                                                                                                                                                                                                                                                                                 | 29/08/2023   | n/a   |           |
| IA/0084/G | This was an application for a group of variations. A.7 - Administrative change - Deletion of manufacturing sites B.I.b.1.d - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Deletion of a non- significant specification parameter (e.g. deletion of an obsolete parameter) B.I.b.1.c - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Addition of a new | 24/07/2023   | n/a   |           |

<div style=\"page-break-after: always\"></div>

|             | specification parameter to the specification with its corresponding test method B.I.b.1.c - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Addition of a new specification parameter to the specification with its corresponding test method B.III.2.b - Change to comply with Ph. Eur. or with a national pharmacopoeia of a Member State - Change to comply with an update of the relevant monograph of the Ph. Eur. or national pharmacopoeia of a Member State A.4 - Administrative change - Change in the name and/or address of a manufacturer or an ASMF holder or supplier of the AS, starting material, reagent or intermediate used in the manufacture of the AS or manufacturer of a novel excipient B.I.b.1.b - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Tightening of   |            |     |
|-------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|
| IAIN/0083/G | This was an application for a group of variations. B.II.b.5.c - Change to in-process tests or limits applied during the manufacture of the finished product - Deletion of a non-significant in-process test B.II.b.2.c.1 - Change to importer, batch release arrangements and quality control testing of the FP - Replacement or addition of a manufacturer responsible for importation and/or batch release - Not including batch control/testing                                                                                                                                                                                                                                                                                                                                                                                                                                                           | 20/07/2023 | n/a |

<div style=\"page-break-after: always\"></div>

| IB/0082/G   | for a group of variations. C.I.11.z - Introduction of, or change(s) to, the obligations and conditions of a marketing authorisation, including the RMP - Other variation C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data is required to be submitted by   | 26/05/2023   | 22/05/2024   | SmPC, Labelling and PL   | This was an application the MAH   |
|-------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|--------------|--------------------------|-----------------------------------|
| N/0081      | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                                                                                                                                                                                                                                                                                | 19/01/2023   | 22/05/2024   | PL                       |                                   |
| IB/0080     | B.I.a.1.k - Change in the manufacturer of AS or of a starting material/reagent/intermediate for AS - New storage site of MCB and/or WCB                                                                                                                                                                                                                                                                                         | 04/01/2023   | n/a          |                          |                                   |
|             | This was an application for a group of variations. B.I.a.2.a - Changes in the manufacturing process of the AS - Minor change in the manufacturing process of the AS B.I.b.1.c - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Addition of a new specification parameter to the specification with its method                                                          | 16/11/2022   | n/a          |                          | IB/0079/G corresponding test      |

<div style=\"page-break-after: always\"></div>

| IAIN/0078          | B.II.b.1.a - Replacement or addition of a manufacturing site for the FP - Secondary packaging site                                                                                                                                                                                                                                                                                                                                                                                                                    | 11/10/2022   | n/a        |    |                                   |
|--------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|------------|----|-----------------------------------|
| PSUSA/1391/ 202109 | Periodic Safety Update EU Single assessment - filgrastim                                                                                                                                                                                                                                                                                                                                                                                                                                                              | 05/05/2022   | n/a        |    | PRAC Recommendation - maintenance |
| N/0076             | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                                                                                                                                                                                                                                                                                                                                                                      | 03/12/2021   | 04/04/2022 | PL |                                   |
| IB/0075            | B.I.a.2.a - Changes in the manufacturing process of the AS - Minor change in the manufacturing process of the AS                                                                                                                                                                                                                                                                                                                                                                                                      | 17/11/2021   | n/a        |    |                                   |
| IA/0074/G          | This was an application for a group of variations. B.III.2.b - Change to comply with Ph. Eur. or with a national pharmacopoeia of a Member State - Change to comply with an update of the relevant monograph of the Ph. Eur. or national pharmacopoeia of a Member State A.4 - Administrative change - Change in the name and/or address of a manufacturer or an ASMF holder or supplier of the AS, starting material, reagent or intermediate used in the manufacture of the AS or manufacturer of a novel excipient | 10/09/2021   | n/a        |    |                                   |
| IB/0073            | B.II.b.3.a - Change in the manufacturing process of the finished or intermediate product - Minor change in the manufacturing process                                                                                                                                                                                                                                                                                                                                                                                  | 04/08/2021   | n/a        |    |                                   |

<div style=\"page-break-after: always\"></div>

<!-- image -->

| IA/0072/G   | This was an application for a group of variations.   | 04/05/2021   | n/a   |
|-------------|------------------------------------------------------|--------------|-------|
| IB/0071/G   | This was an application for a group of variations.   | 13/04/2021   | n/a   |

<div style=\"page-break-after: always\"></div>

<!-- image -->

|         | B.II.b.3.z - Change in the manufacturing process of the finished or intermediate product - Other variation B.II.b.3.z - Change in the manufacturing process of the finished or intermediate product - Other variation                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |            |            |                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
|---------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|----------------------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| WS/1974 | This was an application for a variation following a worksharing procedure according to Article 20 of Commission Regulation (EC) No 1234/2008. To update section 6.4 of the SmPC in order to add finished product in-use storage conditions at room temperature not above 25 °C for a single period of up to 4 days. The package leaflet is updated accordingly. The MAH took also the opportunity to update the results for all filgrastim finished product long-term stability studies, which were presented in the dossier as `on-going', with results from the completed studies. The obtained results support the approved filgrastim drug product shelf-life of 30 months. The MAH also took the opportunity to correct some typos and formatting in line with the latest QRD template 10.1 and to update the list of local reps in the PL. B.II.f.1.c - Stability of FP - Change in storage conditions for biological medicinal products, when the stability studies have not been performed in accordance with an approved stability protocol | 25/03/2021 | 04/04/2022 | SmPC, Annex II, Labelling and PL | The PI is updated to reflect the change in the finished product in-use storage conditions at room temperature not above 25 °C for a single period of up to 4 days. The SmPC section 6.4 has been updated as follows: Within its shelf-life and for ambulatory use, the product may be removed from the refrigerator (2 °C - 8 °C) and stored at a temperature up to 25 °C for one single period of up to 4 days. If not used within 4 days, the product may be returned to the refrigerator (2 °C - 8 °C) up to the expiry date. Dispose of syringes if stored above 8 °C for more than 4 days. The PL has been updated accordingly. |
| II/0069 | Submission of an updated RMP version 10.0 in order to remove the additional pharmacovigilance activity 'Cooperation with SCNIR (Severe Chronic                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       | 01/10/2020 | n/a        |                                  | Not applicable                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |

<div style=\"page-break-after: always\"></div>

|           | Neutropenia International Registry) and analysis of corresponding Ratiograstim/Tevagrastim-SCNIR data'. C.I.11.b - Introduction of, or change(s) to, the obligations and conditions of a marketing authorisation, including the RMP - Implementation of change(s) which require to be further substantiated by new additional data to be submitted by the MAH where significant assessment is required                                                                                                               |            |     |                         |
|-----------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|-------------------------|
| IB/0068   | B.II.d.2.a - Change in test procedure for the finished product - Minor changes to an approved test procedure                                                                                                                                                                                                                                                                                                                                                                                                         | 17/07/2020 | n/a |                         |
| IA/0067   | A.7 - Administrative change - Deletion of sites                                                                                                                                                                                                                                                                                                                                                                                                                                                                      | 26/06/2020 | n/a | manufacturing           |
| IA/0066/G | This was an application for a group of variations. A.4 - Administrative change - Change in the name and/or address of a manufacturer or an ASMF holder or supplier of the AS, starting material, reagent or intermediate used in the manufacture of the AS or manufacturer of a novel excipient A.4 - Administrative change - Change in the name and/or address of a manufacturer or an ASMF holder or supplier of the AS, starting material, reagent or intermediate used in the manufacture of the AS or excipient | 17/04/2020 | n/a | manufacturer of a novel |

<div style=\"page-break-after: always\"></div>

| IB/0065   | - Change to in-process tests or limits during the manufacture of the finished - Other variation                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    | 07/01/2020   | n/a        |          | B.II.b.5.z applied product   |
|-----------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|------------|----------|------------------------------|
| IA/0064/G | This was an application for a group of variations. A.4 - Administrative change - Change in the name and/or address of a manufacturer or an ASMF holder or supplier of the AS, starting material, reagent or intermediate used in the manufacture of the AS or manufacturer of a novel excipient A.4 - Administrative change - Change in the name and/or address of a manufacturer or an ASMF holder or supplier of the AS, starting material, reagent or intermediate used in the manufacture of the AS or manufacturer of a novel excipient A.5.b - Administrative change - Change in the name and/or address of a manufacturer/importer of the finished product, including quality control sites | 18/12/2019   | 17/06/2020 | Annex II | (excluding manufacturer      |
| IA/0063/G | This was an application for a group of variations. A.4 - Administrative change - Change in the name and/or address of a manufacturer or an ASMF holder or supplier of the AS, starting material, reagent or intermediate used in the manufacture of the AS or manufacturer of a novel excipient A.4 - Administrative change - Change in the name and/or address of a manufacturer or an ASMF holder or supplier of the AS, starting material, reagent or in the manufacture of the AS or                                                                                                                                                                                                           | 13/08/2019   | n/a        |          | intermediate used            |

<div style=\"page-break-after: always\"></div>

|         | manufacturer of a novel excipient A.4 - Administrative change - Change in the name and/or address of a manufacturer or an ASMF holder or supplier of the AS, starting material, reagent or intermediate used in the manufacture of the AS or manufacturer of a novel excipient B.III.2.b - Change to comply with Ph. Eur. or with a national pharmacopoeia of a Member State - Change to comply with an update of the relevant monograph of the Ph. Eur. or national pharmacopoeia of a Member State B.III.2.b - Change to comply with Ph. Eur. or with a national pharmacopoeia of a Member State - Change to comply with an update of the relevant monograph of the Ph. Eur. or national pharmacopoeia of a Member State B.III.2.z - Change to comply with Ph. Eur. or with a national pharmacopoeia of a Member State - Other variation B.I.b.1.b - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Tightening of   |            |            |             |
|---------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|-------------|
| IB/0060 | C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data is required to be submitted by the MAH                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   | 21/06/2019 | 17/06/2020 | SmPC and PL |

<div style=\"page-break-after: always\"></div>

| IB/0062            | B.II.b.5.z - Change to in-process tests or limits applied during the manufacture of the finished product - Other variation                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  | 06/06/2019   | n/a        |                     |                                   |
|--------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|------------|---------------------|-----------------------------------|
| PSUSA/1391/ 201809 | Periodic Safety Update EU Single assessment - filgrastim                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    | 16/05/2019   | n/a        |                     | PRAC Recommendation - maintenance |
| IB/0059/G          | This was an application for a group of variations. B.II.e.1.z - Change in immediate packaging of the finished product - Other variation B.II.e.2.a - Change in the specification parameters and/or limits of the immediate packaging of the finished product - Tightening of specification limits B.III.2.z - Change to comply with Ph. Eur. or with a national pharmacopoeia of a Member State - Other variation B.III.2.z - Change to comply with Ph. Eur. or with a national pharmacopoeia of a Member State - Other variation B.II.e.7.a - Change in supplier of packaging components or devices (when mentioned in the | 29/03/2019   | n/a        |                     |                                   |
| IAIN/0057          | B.II.b.2.c.1 - Change to importer, batch release arrangements and quality control testing of the FP - Replacement or addition of a manufacturer responsible for importation and/or batch release - Not including batch control/testing                                                                                                                                                                                                                                                                                                                                                                                      | 12/12/2018   | 13/05/2019 | Annex II and PL     |                                   |
| IAIN/0056          | C.I.z - Changes (Safety/Efficacy) of Human and Veterinary Medicinal Products - Other variation                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              | 31/05/2018   | 13/05/2019 | SmPC, Labelling and |                                   |

<div style=\"page-break-after: always\"></div>

|           |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |            |     | PL   |               |
|-----------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|------|---------------|
| IB/0055   | B.II.b.5.c - Change to in-process tests or limits applied during the manufacture of the finished product - Deletion of a non-significant in-process test                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     | 23/05/2018 | n/a |      |               |
| II/0054   | B.I.b.2.d - Change in test procedure for AS or starting material/reagent/intermediate - Substantial change to or replacement of a biological/immunological/immunochemical test method or a method using a biological reagent for a                                                                                                                                                                                                                                                                                                                                                                                                                                           | 28/09/2017 | n/a |      | biological AS |
| II/0053/G | This was an application for a group of variations. B.I.a.1.z - Change in the manufacturer of AS or of a starting material/reagent/intermediate for AS - Other variation B.I.a.1.z - Change in the manufacturer of AS or of a starting material/reagent/intermediate for AS - Other variation B.I.a.1.z - Change in the manufacturer of AS or of a starting material/reagent/intermediate for AS - Other variation B.I.a.2.c - Changes in the manufacturing process of the AS - The change refers to a [-] substance in the manufacture of a biological/immunological substance which may have a significant impact on the medicinal product and is not related to a protocol | 06/07/2017 | n/a |      |               |
| II/0052   | B.II.b.4.c - Change in the batch size (including batch size ranges) of the finished product - The change                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     | 10/11/2016 | n/a |      |               |

<div style=\"page-break-after: always\"></div>

|                    | requires assessment of the comparability of a biological/immunological medicinal product or a new bioequivalence study                                                                                                                                                                                                     |            |            |                 |                                   |
|--------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|-----------------|-----------------------------------|
| IB/0051            | C.I.11.z - Introduction of, or change(s) to, the obligations and conditions of a marketing authorisation, including the RMP - Other variation                                                                                                                                                                              | 26/09/2016 | n/a        |                 |                                   |
| IAIN/0050          | A.5.a - Administrative change - Change in the name and/or address of a manufacturer/importer responsible for batch release                                                                                                                                                                                                 | 12/07/2016 | 18/05/2017 | Annex II and PL |                                   |
| IB/0049/G          | This was an application for a group of variations. B.I.b.2.a - Change in test procedure for AS or starting material/reagent/intermediate - Minor changes to an approved test procedure B.I.b.2.a - Change in test procedure for AS or starting material/reagent/intermediate - Minor changes to an approved test procedure | 08/06/2016 | n/a        |                 |                                   |
| PSUSA/1391/ 201509 | Periodic Safety Update EU Single assessment - filgrastim                                                                                                                                                                                                                                                                   | 13/05/2016 | n/a        |                 | PRAC Recommendation - maintenance |
| II/0046/G          | This was an application for a group of variations. B.II.d.1.e - Change in the specification parameters and/or limits of the finished product - Change outside the approved specifications limits range B.II.f.1.e - Stability of FP - Change to an approved stability protocol                                             | 07/04/2016 | n/a        |                 |                                   |

<div style=\"page-break-after: always\"></div>

| IB/0048   | B.I.a.1.z - Change in the manufacturer of AS or of a starting material/reagent/intermediate for AS - Other variation                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     | 18/03/2016   | n/a        |    |                     |
|-----------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|------------|----|---------------------|
| N/0047    | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         | 03/02/2016   | 18/05/2017 | PL |                     |
| II/0044   | B.II.b.2.b - Change to importer, batch release arrangements and quality control testing of the FP - Replacement/addition of a site where batch control/testing takes place for a biol/immunol product and any of the test methods at the site is a                                                                                                                                                                                                                                                                                                                                                                       | 05/11/2015   | n/a        |    | biol/immunol method |
| IB/0043   | B.II.b.3.z - Change in the manufacturing process of the finished or intermediate product - Other variation                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               | 07/04/2015   | n/a        |    |                     |
| IB/0042/G | This was an application for a group of variations. B.II.b.2.a - Change to importer, batch release arrangements and quality control testing of the FP - Replacement/addition of a site where batch control/testing takes place B.II.b.2.a - Change to importer, batch release arrangements and quality control testing of the FP - Replacement/addition of a site where batch control/testing takes place B.II.d.2.a - Change in test procedure for the finished product - Minor changes to an approved test procedure B.II.d.2.d - Change in test procedure for the finished product - Other changes to a test procedure | 30/01/2015   | n/a        |    |                     |

<div style=\"page-break-after: always\"></div>

|         | (including replacement or addition) B.II.d.2.d - Change in test procedure for the finished product - Other changes to a test procedure (including replacement or addition) B.II.f.1.e - Stability of FP - Change to an approved stability protocol   |            |     |           |
|---------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|-----------|
| IA/0041 | A.7 - Administrative change - Deletion of manufacturing sites                                                                                                                                                                                        | 03/10/2014 | n/a |           |
| IB/0040 | B.I.a.1.k - Change in the manufacturer of AS or of a starting material/reagent/intermediate for AS - New storage site of MCB and/or WCB                                                                                                              | 29/08/2014 | n/a |           |
|         | This was an application for a group of variations. A.7 - Administrative change - Deletion of manufacturing sites B.II.b.3.z - Change in the manufacturing process of the finished or intermediate product - Other variation                          | 15/08/2014 | n/a | IA/0039/G |
| IB/0038 | B.I.c.1.z - Change in immediate packaging of the AS - Other variation                                                                                                                                                                                | 22/07/2014 | n/a |           |
| IB/0037 | B.I.c.z - Container closure system of the AS - Other variation                                                                                                                                                                                       | 28/05/2014 | n/a |           |
| IB/0036 | B.I.b.1.z - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Other variation                                                                                                                  | 20/05/2014 | n/a |           |

<div style=\"page-break-after: always\"></div>

| IA/0035/G   | a group of variations. B.III.2.a.2 - Change of specification(s) of a former non EU Pharmacopoeial substance to fully comply with the Ph. Eur. or with a national pharmacopoeia of a Member State - Excipient/AS starting material B.III.2.a.2 - Change of specification(s) of a former non EU Pharmacopoeial substance to fully comply with the Ph. Eur. or with a national pharmacopoeia of a Member State - Excipient/AS starting material   | 12/03/2014   | n/a   | This was an application for   |
|-------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|-------|-------------------------------|
| IB/0034     | B.I.b.1.z - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Other variation                                                                                                                                                                                                                                                                                                            | 24/01/2014   | n/a   |                               |
|             | This was an application for a group of variations. B.I.b.2.e - Change in test procedure for AS or starting material/reagent/intermediate - Other changes to a test procedure (including replacement or addition) for the AS or a starting material/intermediate B.II.d.2.d - Change in test procedure for the finished product - Other changes to a test procedure (including replacement or addition)                                         | 17/12/2013   | n/a   | IB/0033/G                     |
| IA/0032/G   | This was an application for a group of variations. B.III.2.a.2 - Change of specification(s) of a former non EU Pharmacopoeial substance to fully comply with the Ph. Eur. or with a national pharmacopoeia of a Member State - Excipient/AS starting material                                                                                                                                                                                  | 22/11/2013   | n/a   |                               |

<div style=\"page-break-after: always\"></div>

|         | B.III.2.a.2 - Change of specification(s) of a former non EU Pharmacopoeial substance to fully comply with the Ph. Eur. or with a national pharmacopoeia of a Member State - Excipient/AS starting material B.III.2.a.2 - Change of specification(s) of a former non EU Pharmacopoeial substance to fully comply with the Ph. Eur. or with a national pharmacopoeia of a Member State - Excipient/AS starting material B.III.2.a.2 - Change of specification(s) of a former non EU Pharmacopoeial substance to fully comply with the Ph. Eur. or with a national pharmacopoeia of a Member State - Excipient/AS starting material B.III.2.a.2 - Change of specification(s) of a former non EU Pharmacopoeial substance to fully comply with the Ph. Eur. or with a national pharmacopoeia of a Member State - Excipient/AS starting material   |            |            |             |                                                                                                                                                                                                           |
|---------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|-------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| IB/0030 | C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data is required to be submitted by the MAH C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data is required to be submitted by the MAH                                                                                                                                                                                                                                                                                                                     | 30/10/2013 | 04/12/2014 | SmPC and PL | Update of sections 4.4 and 4.8 of the SmPC to include a new adverse reaction, capillary leak syndrome, and a related warning following the same update for the originator. The PL is updated accordingly. |

<div style=\"page-break-after: always\"></div>

|           | B.II.e.2.a - Change in the specification parameters and/or limits of the immediate packaging of the finished product - Tightening of specification limits                                                                                                                                                | 15/10/2013   | n/a        |                                  | IA/0031                      |
|-----------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|------------|----------------------------------|------------------------------|
| R/0027    | Renewal of the marketing authorisation.                                                                                                                                                                                                                                                                  | 30/05/2013   | 19/07/2013 | SmPC, Annex II, Labelling and PL |                              |
| IA/0029/G | This was an application for a group of variations. B.II.b.3.z - Change in the manufacturing process of the finished product - Other variation B.II.b.5.c - Change to in-process tests or limits applied during the manufacture of the finished product - Deletion of a non-significant in-process test   | 11/07/2013   | n/a        |                                  |                              |
| IA/0028   | B.II.e.2.a - Change in the specification parameters and/or limits of the immediate packaging of the finished product - Tightening of specification limits                                                                                                                                                | 11/04/2013   | n/a        |                                  |                              |
|           | This was an application for a group of variations. B.II.b.5.z - Change to in-process tests or limits applied during the manufacture of the finished product - Other variation B.II.b.5.b - Change to in-process tests or limits applied during the manufacture of the finished of a new tests and limits | 18/01/2013   | n/a        |                                  | IB/0026/G product - Addition |
| II/0024/G | This was an application for a group of variations. To introduce a new site for WCB manufacture.                                                                                                                                                                                                          | 15/11/2012   | n/a        |                                  |                              |

<div style=\"page-break-after: always\"></div>

|           | To introduce a new WCB lot and some modifications to the manufacturing process of the WCB (change in scale, harvesting time and freezing volume). B.I.a.1.e - Change in the manufacturer of AS or of a starting material/reagent/intermediate for AS - The change relates to a biological AS or a starting material [-] used in the manufacture of a biological/immunological product B.I.a.2.c - Changes in the manufacturing process of the AS - The change refers to a [-] substance in the manufacture of a biological/immunological medicinal product and is not related to a protocol   |            |            |                                  |
|-----------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|----------------------------------|
| IB/0025   | C.I.3.a - Implementation of change(s) requested following the assessment of an USR, class labelling, a PSUR, RMP, FUM/SO, data submitted under A 45/46, or amendments to reflect a Core SPC - Changes with NO new additional data are submitted by the MAH                                                                                                                                                                                                                                                                                                                                    | 24/10/2012 | 31/10/2012 | SmPC, Annex II, Labelling and PL |
| IB/0022/G | This was an application for a group of variations. B.I.b.2.a - Change in test procedure for AS or starting material/reagent/intermediate - Minor changes to an approved test procedure B.I.a.4.z - Change to in-process tests or limits applied during the manufacture of the AS - Other variation                                                                                                                                                                                                                                                                                            | 21/09/2012 | n/a        |                                  |
| IA/0023   | A.5.b - Administrative change - Change in the name and/or address of a manufacturer of the finished                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           | 12/09/2012 | n/a        |                                  |

<div style=\"page-break-after: always\"></div>

|           | product, including quality control sites (excluding manufacturer for batch release)                                                                                                                                                                                                                                                                                                                                                                     |            |     |             |
|-----------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|-------------|
| II/0021   | Replacement of the peptide mapping method. B.I.b.2.d - Change in test procedure for AS or starting material/reagent/intermediate - Change (replacement) to a biological/immunological/ immunochemical test method or a method using a biological reagent for a biological AS                                                                                                                                                                            | 19/07/2012 | n/a |             |
| IB/0019   | B.I.b.2.e - Change in test procedure for AS or starting material/reagent/intermediate - Other changes to a test procedure (including replacement or addition) for the AS or a starting material/intermediate                                                                                                                                                                                                                                            | 10/05/2012 | n/a |             |
| IA/0018/G | application for a group of variations. B.I.c.2.b - Change in the specification parameters and/or limits of the immediate packaging of the AS - Addition of a new specification parameter to the specification with its corresponding test method B.I.c.2.c - Change in the specification parameters and/or limits of the immediate packaging of the AS - Deletion of a non-significant specification parameter (e.g. deletion of an obsolete parameter) | 14/03/2012 | n/a | This was an |
| IB/0017   | B.I.a.3.e - Change in batch size (including batch size ranges) of AS or intermediate - The scale for a biological/immunological AS is increased/decreased without process change (e.g. duplication of line)                                                                                                                                                                                                                                             | 08/12/2011 | n/a |             |

<div style=\"page-break-after: always\"></div>

| IA/0016/G   | This was an application for a group of variations. B.I.b.1.b - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Tightening of specification limits B.II.d.1.a - Change in the specification parameters and/or limits of the finished product - Tightening of specification limits B.I.d.1.a.1 - Stability of AS - Change in the re-test period/storage period - Reduction                                                                                                                                          | 25/10/2011   | n/a        |          |                                                                                                                                                                                                                           |
|-------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|------------|----------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| II/0015/G   | This was an application for a group of variations. Introduction of additional sterile filtration steps in the manufacturing process for the active substance. In addition, new in-process tests and limits are introduced. B.I.a.2.c - Changes in the manufacturing process of the AS - The change refers to a [-] substance in the manufacture of a biological/immunological medicinal product and is not related to a protocol B.I.a.4.b - Change to in-process tests or limits applied during the manufacture of the AS - Addition of a new in-process test and limits | 20/10/2011   | n/a        |          |                                                                                                                                                                                                                           |
| II/0013     | Introduction of a new Pharmacovigilance System (TEVA DDPS Version 10), including a new Qualified person for Pharmacovigilance.                                                                                                                                                                                                                                                                                                                                                                                                                                            | 23/06/2011   | 20/07/2011 | Annex II | The MAH has introduced a new pharmacovigilance system used by TEVA Pharmaceutical Industries Ltd., which will be applied for the product Ratiograstim. The detailed description of this pharmacovigilance system includes |

<div style=\"page-break-after: always\"></div>

|           | Annex II.B has also been updated with the latest wording as per October 2010 CHMP procedural announcement. C.I.8.a - Introduction of a new Pharmacovigilance system - which has not been assessed by the relevant NCA/EMA for another product of the same MAH                                                                                                                                                                                                                                                                                                |            |     |             | information pertaining to the qualified person responsible for pharmacovigilance, the global structure of the pharmacovigilance organisation, company procedures relating to pharmacovigilance activities, global safety databases, links with other organisations, training and the quality management system. The MAH has also taken the opportunity to update Annex II.B with the latest wording as per October 2010 CHMP procedural announcement.   |
|-----------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|-------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| IB/0014/G | This was an application for a group of variations. B.I.b.2.a - Change in test procedure for AS or starting material/reagent/intermediate - Minor changes to an approved test procedure B.II.d.2.a - Change in test procedure for the finished product - Minor changes to an approved test procedure                                                                                                                                                                                                                                                          | 20/07/2011 | n/a |             |                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
| IB/0012/G | This was an application for a group of variations. C.I.3.a - Implementation of change(s) requested following the assessment of an USR, class labelling, a PSUR, RMP, FUM/SO, data submitted under A 45/46, or amendments to reflect a Core SPC - Changes with NO new additional data are submitted by the MAH C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data are submitted by the MAH | 21/02/2011 | n/a | SmPC and PL | To implement changes requested in the PSUR 3 Assessment Report (dated 06 August 2010), as well as to bring the Product Information in line with the SmPC of the reference product (Neupogen). Minor linguistic amendments are introduced in the Package Leaflet for the following languages: CS, DA, ET, ES, FI, FR, HU, IT, NL, PL . In addition, the MAH amended the European Medicines Agency web address in section 10 of the SmPC.                 |

<div style=\"page-break-after: always\"></div>

| IA/0011   | B.II.b.1.a - Replacement or addition of a manufacturing site for the FP - Secondary packaging site                                                                                                                                                                                                                                     | 22/09/2010   | n/a        |                       |
|-----------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|------------|-----------------------|
| IB/0010   | B.II.d.2.d - Change in test procedure for the finished product - Other changes to a test procedure (including replacement or addition)                                                                                                                                                                                                 | 27/08/2010   | n/a        |                       |
| II/0007   | Addition of an alternative site for manufacture (formulation, filling) of drug product. B.II.b.1.c - Replacement or addition of a manufacturing site for the FP - Site where any manufacturing operation(s) take place, except batch release, batch control, and secondary packaging, for biological/immunological medicinal products. | 24/06/2010   | 01/07/2010 |                       |
| IB/0009   | To change a test procedure for the finished product B.II.d.2.d - Change in test procedure for the finished product - Other changes to a test procedure (including replacement or addition)                                                                                                                                             | 20/05/2010   | n/a        |                       |
| IB/0008   | To change a test procedure for the active substance B.I.b.2.e - Change in test procedure for AS or starting material/reagent/intermediate - Other changes to a test procedure (including replacement or addition) for the AS or a starting                                                                                             | 20/05/2010   | n/a        | material/intermediate |

<div style=\"page-break-after: always\"></div>

| IA/0006   | B.II.e.6.a - Change in any part of the (primary) packaging material not in contact with the finished product formulation - Change that affects the product information   | 05/03/2010   | n/a        | PL                     |
|-----------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|------------|------------------------|
| II/0001   | Extension of the finished product shelf-life from 24 to 30 months. Change(s) to shelf-life or storage conditions                                                         | 19/11/2009   | 08/01/2010 | SmPC, Labelling and PL |
| IA/0005   | IA_28_Change in any part of primary packaging material not in contact with finished product                                                                              | 06/10/2009   | 06/10/2009 | SmPC, Labelling and PL |
| IA/0004   | IA_28_Change in any part of primary packaging material not in contact with finished product                                                                              | 06/10/2009   | 06/10/2009 | SmPC, Labelling and PL |
| IA/0003   | IA_28_Change in any part of primary packaging material not in contact with finished product                                                                              | 06/10/2009   | 06/10/2009 | SmPC, Labelling and PL |
| IA/0002   | IA_28_Change in any part of primary packaging material not in contact with finished product                                                                              | 06/10/2009   | 06/10/2009 | SmPC, Labelling and PL |